Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Crohn Disease | 72 | 2023 | 2299 | 5.310 |
Why?
|
Colitis, Ulcerative | 55 | 2023 | 1899 | 4.740 |
Why?
|
Inflammatory Bowel Diseases | 53 | 2023 | 2397 | 4.200 |
Why?
|
Immunosuppressive Agents | 25 | 2022 | 4143 | 1.870 |
Why?
|
Gastrointestinal Agents | 10 | 2023 | 494 | 1.520 |
Why?
|
Immunologic Factors | 13 | 2023 | 1571 | 1.430 |
Why?
|
Tacrolimus | 8 | 2023 | 739 | 1.160 |
Why?
|
Child | 138 | 2023 | 77033 | 1.040 |
Why?
|
Azathioprine | 8 | 2022 | 355 | 0.970 |
Why?
|
Proctocolectomy, Restorative | 3 | 2023 | 189 | 0.940 |
Why?
|
Helicobacter pylori | 2 | 2023 | 379 | 0.900 |
Why?
|
Helicobacter Infections | 2 | 2023 | 384 | 0.900 |
Why?
|
Anti-Inflammatory Agents | 13 | 2019 | 1777 | 0.800 |
Why?
|
Ileum | 6 | 2023 | 563 | 0.790 |
Why?
|
Methotrexate | 3 | 2023 | 1711 | 0.740 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2022 | 395 | 0.710 |
Why?
|
Adrenal Cortex Hormones | 17 | 2019 | 1833 | 0.710 |
Why?
|
Gastroenterology | 7 | 2018 | 533 | 0.690 |
Why?
|
Adolescent | 100 | 2023 | 85405 | 0.670 |
Why?
|
Metronidazole | 4 | 2023 | 216 | 0.670 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 146 | 0.660 |
Why?
|
Thalidomide | 4 | 2016 | 878 | 0.620 |
Why?
|
Electric Power Supplies | 1 | 2018 | 99 | 0.610 |
Why?
|
Antibodies, Monoclonal | 14 | 2023 | 9259 | 0.560 |
Why?
|
Lymphoma | 4 | 2013 | 1873 | 0.500 |
Why?
|
Hereditary Angioedema Types I and II | 1 | 2014 | 10 | 0.490 |
Why?
|
Metagenome | 3 | 2012 | 417 | 0.490 |
Why?
|
Immunocompromised Host | 4 | 2014 | 845 | 0.470 |
Why?
|
Mesalamine | 7 | 2022 | 135 | 0.470 |
Why?
|
Intestines | 6 | 2022 | 1919 | 0.460 |
Why?
|
Digestive System Surgical Procedures | 3 | 2014 | 568 | 0.450 |
Why?
|
Bacteroidetes | 1 | 2013 | 83 | 0.450 |
Why?
|
Gastrointestinal Diseases | 3 | 2014 | 1162 | 0.450 |
Why?
|
Intestinal Mucosa | 10 | 2020 | 3036 | 0.440 |
Why?
|
Colon | 12 | 2020 | 1771 | 0.440 |
Why?
|
Child, Preschool | 52 | 2022 | 40802 | 0.440 |
Why?
|
Humans | 173 | 2023 | 739398 | 0.420 |
Why?
|
Enterotoxins | 1 | 2013 | 366 | 0.410 |
Why?
|
Hospitals, Pediatric | 2 | 2018 | 1744 | 0.400 |
Why?
|
Biological Therapy | 1 | 2013 | 138 | 0.400 |
Why?
|
Child Welfare | 2 | 2014 | 520 | 0.400 |
Why?
|
Abdominal Pain | 6 | 2014 | 1053 | 0.380 |
Why?
|
Chickenpox Vaccine | 1 | 2010 | 83 | 0.370 |
Why?
|
Biological Products | 3 | 2019 | 850 | 0.360 |
Why?
|
Esophagitis | 4 | 2023 | 151 | 0.360 |
Why?
|
Genes, Bacterial | 1 | 2013 | 1078 | 0.350 |
Why?
|
Chickenpox | 1 | 2010 | 133 | 0.350 |
Why?
|
Nutritional Status | 3 | 2014 | 1587 | 0.350 |
Why?
|
Antibodies | 3 | 2023 | 2450 | 0.350 |
Why?
|
Male | 106 | 2023 | 349022 | 0.340 |
Why?
|
Female | 111 | 2023 | 378853 | 0.340 |
Why?
|
Mouth | 1 | 2011 | 372 | 0.330 |
Why?
|
Influenza B virus | 1 | 2009 | 49 | 0.330 |
Why?
|
Child Nutrition Disorders | 2 | 2008 | 148 | 0.330 |
Why?
|
Colitis | 5 | 2017 | 1146 | 0.330 |
Why?
|
Remission Induction | 11 | 2019 | 2378 | 0.330 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2009 | 89 | 0.330 |
Why?
|
Tongue | 1 | 2011 | 413 | 0.320 |
Why?
|
Vaccination | 6 | 2023 | 3232 | 0.320 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1603 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2023 | 4400 | 0.310 |
Why?
|
Diarrhea | 2 | 2013 | 1342 | 0.310 |
Why?
|
Young Adult | 27 | 2023 | 56255 | 0.310 |
Why?
|
Bacterial Toxins | 1 | 2013 | 938 | 0.300 |
Why?
|
Azithromycin | 2 | 2019 | 194 | 0.300 |
Why?
|
Endoscopy | 2 | 2017 | 1762 | 0.300 |
Why?
|
Receptors, Interleukin-10 | 2 | 2017 | 50 | 0.300 |
Why?
|
Treatment Outcome | 35 | 2023 | 62693 | 0.300 |
Why?
|
Probiotics | 3 | 2006 | 350 | 0.300 |
Why?
|
Growth Disorders | 3 | 2009 | 644 | 0.300 |
Why?
|
Anxiety | 4 | 2018 | 4253 | 0.300 |
Why?
|
Severity of Illness Index | 25 | 2022 | 15511 | 0.290 |
Why?
|
Depression | 10 | 2016 | 7689 | 0.290 |
Why?
|
Family Leave | 1 | 2006 | 18 | 0.290 |
Why?
|
Clostridium Infections | 1 | 2013 | 549 | 0.280 |
Why?
|
Child Advocacy | 1 | 2006 | 49 | 0.280 |
Why?
|
Clarithromycin | 2 | 2023 | 86 | 0.280 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2023 | 857 | 0.280 |
Why?
|
Social Security | 1 | 2006 | 100 | 0.280 |
Why?
|
Adaptive Immunity | 1 | 2010 | 709 | 0.260 |
Why?
|
Lactobacillus | 2 | 2005 | 188 | 0.260 |
Why?
|
Postoperative Complications | 2 | 2017 | 15194 | 0.250 |
Why?
|
Anti-Bacterial Agents | 9 | 2023 | 7136 | 0.250 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.250 |
Why?
|
Drug Resistance | 1 | 2010 | 1610 | 0.240 |
Why?
|
Patient Advocacy | 1 | 2006 | 353 | 0.240 |
Why?
|
Bacteria | 2 | 2012 | 2106 | 0.240 |
Why?
|
Agar | 1 | 2023 | 56 | 0.230 |
Why?
|
Eating | 4 | 2018 | 1526 | 0.220 |
Why?
|
Prospective Studies | 31 | 2023 | 53037 | 0.220 |
Why?
|
Societies, Medical | 3 | 2014 | 3739 | 0.220 |
Why?
|
RNA, Ribosomal, 16S | 4 | 2019 | 946 | 0.220 |
Why?
|
Sulfasalazine | 1 | 2022 | 79 | 0.220 |
Why?
|
Amoxicillin | 1 | 2023 | 165 | 0.210 |
Why?
|
Education, Medical, Continuing | 2 | 2018 | 840 | 0.210 |
Why?
|
Psychotherapy | 3 | 2016 | 1638 | 0.210 |
Why?
|
Homocysteine | 1 | 2005 | 647 | 0.200 |
Why?
|
Drug Therapy, Combination | 8 | 2019 | 6478 | 0.200 |
Why?
|
Pancytopenia | 1 | 2002 | 104 | 0.200 |
Why?
|
Adult | 45 | 2022 | 213394 | 0.200 |
Why?
|
Interleukin-10 | 2 | 2017 | 1199 | 0.200 |
Why?
|
Intestinal Perforation | 2 | 2014 | 252 | 0.200 |
Why?
|
Influenza Vaccines | 1 | 2009 | 740 | 0.200 |
Why?
|
Methyltransferases | 2 | 2009 | 366 | 0.190 |
Why?
|
Follow-Up Studies | 20 | 2015 | 38942 | 0.190 |
Why?
|
Vaccines | 1 | 2009 | 802 | 0.190 |
Why?
|
Immunity, Humoral | 2 | 2022 | 595 | 0.190 |
Why?
|
Depressive Disorder | 4 | 2015 | 3743 | 0.190 |
Why?
|
Malabsorption Syndromes | 2 | 2015 | 135 | 0.190 |
Why?
|
Anal Canal | 1 | 2023 | 373 | 0.190 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1866 | 0.190 |
Why?
|
Retrospective Studies | 25 | 2023 | 76631 | 0.190 |
Why?
|
Hepatocyte Growth Factor | 1 | 2001 | 270 | 0.180 |
Why?
|
Colonoscopy | 5 | 2022 | 1363 | 0.180 |
Why?
|
Endothelial Growth Factors | 2 | 2001 | 695 | 0.180 |
Why?
|
Anastomosis, Surgical | 1 | 2023 | 983 | 0.180 |
Why?
|
Immunity, Innate | 2 | 2016 | 2950 | 0.180 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3866 | 0.180 |
Why?
|
Propranolol | 1 | 2001 | 499 | 0.180 |
Why?
|
Foreign Bodies | 2 | 2015 | 398 | 0.170 |
Why?
|
Ileitis | 1 | 2019 | 44 | 0.170 |
Why?
|
Lymphokines | 2 | 2001 | 950 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2014 | 2277 | 0.170 |
Why?
|
Biomedical Research | 3 | 2019 | 3301 | 0.170 |
Why?
|
Drug Resistance, Bacterial | 2 | 2023 | 1031 | 0.170 |
Why?
|
Parvoviridae Infections | 1 | 1998 | 34 | 0.170 |
Why?
|
Parvovirus B19, Human | 1 | 1998 | 37 | 0.170 |
Why?
|
Case-Control Studies | 11 | 2020 | 21694 | 0.170 |
Why?
|
Anemia | 1 | 2008 | 1498 | 0.170 |
Why?
|
Osteoporosis | 1 | 2008 | 1576 | 0.160 |
Why?
|
Vitamin A Deficiency | 2 | 2001 | 101 | 0.160 |
Why?
|
Hospital Departments | 1 | 2018 | 137 | 0.160 |
Why?
|
Vitamin E Deficiency | 1 | 1998 | 33 | 0.160 |
Why?
|
Hepatitis, Viral, Human | 1 | 1998 | 137 | 0.160 |
Why?
|
Ileus | 1 | 2017 | 58 | 0.160 |
Why?
|
Metabolic Clearance Rate | 1 | 2018 | 380 | 0.150 |
Why?
|
Surgical Stomas | 1 | 2017 | 43 | 0.150 |
Why?
|
Clinical Trials as Topic | 4 | 2019 | 7897 | 0.150 |
Why?
|
Complementary Therapies | 1 | 2002 | 484 | 0.150 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2001 | 231 | 0.150 |
Why?
|
Influenza, Human | 1 | 2009 | 1476 | 0.150 |
Why?
|
Infant | 17 | 2018 | 34923 | 0.150 |
Why?
|
Ileostomy | 1 | 2017 | 119 | 0.150 |
Why?
|
Immunotoxins | 1 | 1997 | 179 | 0.140 |
Why?
|
Colonic Pouches | 2 | 2009 | 121 | 0.140 |
Why?
|
Play and Playthings | 1 | 2017 | 79 | 0.140 |
Why?
|
Oral Ulcer | 1 | 2017 | 96 | 0.140 |
Why?
|
Diphtheria Toxin | 1 | 1997 | 255 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 199 | 0.140 |
Why?
|
Neurofibromatosis 1 | 1 | 2001 | 558 | 0.140 |
Why?
|
Skin Ulcer | 1 | 2017 | 118 | 0.140 |
Why?
|
Prognosis | 10 | 2019 | 28901 | 0.140 |
Why?
|
Inservice Training | 1 | 2018 | 391 | 0.140 |
Why?
|
Inflammation | 6 | 2019 | 10534 | 0.140 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 276 | 0.140 |
Why?
|
Myositis | 1 | 1998 | 248 | 0.130 |
Why?
|
Osteomyelitis | 1 | 1999 | 398 | 0.130 |
Why?
|
Lung Diseases, Fungal | 1 | 2016 | 122 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2020 | 1858 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 327 | 0.130 |
Why?
|
Lymphocytes | 1 | 2003 | 2612 | 0.130 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7274 | 0.130 |
Why?
|
Duodenum | 2 | 2015 | 481 | 0.130 |
Why?
|
Enteral Nutrition | 4 | 2009 | 758 | 0.130 |
Why?
|
Lactase | 1 | 2015 | 69 | 0.130 |
Why?
|
Insurance Coverage | 1 | 2006 | 1891 | 0.130 |
Why?
|
Registries | 11 | 2015 | 8039 | 0.130 |
Why?
|
Receptors, Interleukin-2 | 1 | 1996 | 572 | 0.130 |
Why?
|
Microvilli | 1 | 2015 | 241 | 0.120 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1997 | 600 | 0.120 |
Why?
|
Observer Variation | 2 | 2018 | 2589 | 0.120 |
Why?
|
Nausea | 2 | 2014 | 656 | 0.120 |
Why?
|
Colic | 1 | 2014 | 42 | 0.120 |
Why?
|
Disease Progression | 5 | 2018 | 13237 | 0.120 |
Why?
|
Genes, Dominant | 1 | 2017 | 883 | 0.120 |
Why?
|
Mucolipidoses | 1 | 2015 | 82 | 0.120 |
Why?
|
Autistic Disorder | 1 | 2023 | 1164 | 0.120 |
Why?
|
Prednisone | 3 | 2014 | 1560 | 0.120 |
Why?
|
Intestinal Obstruction | 1 | 2017 | 425 | 0.120 |
Why?
|
Laparoscopy | 2 | 2016 | 2091 | 0.120 |
Why?
|
Odds Ratio | 5 | 2022 | 9846 | 0.120 |
Why?
|
Pediatrics | 3 | 2017 | 3454 | 0.120 |
Why?
|
Gastrointestinal Tract | 2 | 2012 | 814 | 0.120 |
Why?
|
Biopsy | 5 | 2019 | 6722 | 0.120 |
Why?
|
Certification | 1 | 2017 | 424 | 0.120 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1997 | 640 | 0.110 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 24714 | 0.110 |
Why?
|
Intestinal Fistula | 1 | 2014 | 140 | 0.110 |
Why?
|
Constipation | 1 | 2018 | 541 | 0.110 |
Why?
|
Blood Sedimentation | 4 | 2014 | 232 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 920 | 0.110 |
Why?
|
Laparotomy | 1 | 2015 | 472 | 0.110 |
Why?
|
Reproducibility of Results | 8 | 2022 | 19811 | 0.110 |
Why?
|
Bacteroides fragilis | 1 | 2013 | 212 | 0.110 |
Why?
|
Intestine, Small | 1 | 2018 | 1242 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9387 | 0.100 |
Why?
|
Endpoint Determination | 2 | 2005 | 598 | 0.100 |
Why?
|
Budesonide | 1 | 2012 | 154 | 0.100 |
Why?
|
United States | 13 | 2023 | 69573 | 0.100 |
Why?
|
Intestinal Diseases | 1 | 1996 | 531 | 0.100 |
Why?
|
Th17 Cells | 1 | 2017 | 760 | 0.100 |
Why?
|
Leukocytes | 1 | 2019 | 2035 | 0.100 |
Why?
|
Deglutition | 1 | 2012 | 199 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3571 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2016 | 970 | 0.100 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2016 | 703 | 0.090 |
Why?
|
Erythema Nodosum | 1 | 2010 | 30 | 0.090 |
Why?
|
Nutritional Support | 2 | 2011 | 168 | 0.090 |
Why?
|
Psychophysiologic Disorders | 1 | 2012 | 228 | 0.090 |
Why?
|
Feces | 2 | 2013 | 1389 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 1998 | 804 | 0.090 |
Why?
|
Interleukin-2 | 1 | 1997 | 1883 | 0.090 |
Why?
|
Expert Testimony | 1 | 2013 | 355 | 0.090 |
Why?
|
Age of Onset | 4 | 2022 | 3263 | 0.090 |
Why?
|
Stomatitis, Aphthous | 1 | 2010 | 51 | 0.090 |
Why?
|
Information Systems | 1 | 2012 | 410 | 0.090 |
Why?
|
Thromboembolism | 2 | 2013 | 984 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1150 | 0.090 |
Why?
|
Logistic Models | 4 | 2018 | 13402 | 0.090 |
Why?
|
Personality Inventory | 1 | 2012 | 1026 | 0.090 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 261 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2001 | 1606 | 0.080 |
Why?
|
Prevalence | 6 | 2019 | 15153 | 0.080 |
Why?
|
Anus Diseases | 1 | 2009 | 59 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12237 | 0.080 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2001 | 773 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3510 | 0.080 |
Why?
|
Boston | 2 | 2018 | 9314 | 0.080 |
Why?
|
Leukocyte L1 Antigen Complex | 2 | 2022 | 88 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6174 | 0.080 |
Why?
|
North America | 4 | 2017 | 1249 | 0.080 |
Why?
|
Sleep | 2 | 2014 | 4596 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 3863 | 0.080 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2009 | 224 | 0.080 |
Why?
|
Interleukin-6 | 2 | 2001 | 3194 | 0.080 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2007 | 87 | 0.080 |
Why?
|
Quality of Life | 4 | 2019 | 12640 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2261 | 0.080 |
Why?
|
Internet | 2 | 2017 | 3048 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2013 | 1117 | 0.070 |
Why?
|
Growth | 1 | 2009 | 377 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2013 | 490 | 0.070 |
Why?
|
Genetic Research | 1 | 2007 | 172 | 0.070 |
Why?
|
Child Behavior | 1 | 2012 | 836 | 0.070 |
Why?
|
Phenotype | 6 | 2022 | 16301 | 0.070 |
Why?
|
Thioguanine | 1 | 2006 | 46 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2012 | 821 | 0.070 |
Why?
|
DNA, Bacterial | 1 | 2011 | 1467 | 0.070 |
Why?
|
Receptors, Interleukin | 1 | 2007 | 243 | 0.070 |
Why?
|
Chronic Disease | 4 | 2017 | 9133 | 0.070 |
Why?
|
Recurrence | 4 | 2005 | 8307 | 0.070 |
Why?
|
Hematologic Tests | 1 | 2007 | 237 | 0.070 |
Why?
|
Arthralgia | 1 | 2010 | 457 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2018 | 1867 | 0.070 |
Why?
|
Capsule Endoscopy | 1 | 2007 | 125 | 0.070 |
Why?
|
Wound Healing | 1 | 1997 | 2768 | 0.070 |
Why?
|
Research | 2 | 2006 | 2001 | 0.070 |
Why?
|
Intestinal Absorption | 1 | 2006 | 420 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2003 | 3137 | 0.070 |
Why?
|
Neoplasms | 1 | 2014 | 21507 | 0.060 |
Why?
|
Antibodies, Fungal | 1 | 2004 | 32 | 0.060 |
Why?
|
Nutrition Disorders | 1 | 2006 | 210 | 0.060 |
Why?
|
Time Factors | 6 | 2017 | 40050 | 0.060 |
Why?
|
Antimetabolites | 1 | 2005 | 125 | 0.060 |
Why?
|
Vomiting | 1 | 2008 | 622 | 0.060 |
Why?
|
Physicians | 2 | 2021 | 4539 | 0.060 |
Why?
|
Probability | 2 | 2018 | 2500 | 0.060 |
Why?
|
Porins | 1 | 2004 | 81 | 0.060 |
Why?
|
Self Report | 2 | 2016 | 3524 | 0.060 |
Why?
|
Reference Values | 3 | 2007 | 4983 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2012 | 6370 | 0.060 |
Why?
|
Bone Diseases, Metabolic | 1 | 2008 | 417 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 1996 | 2116 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 2986 | 0.060 |
Why?
|
Age Factors | 5 | 2022 | 18349 | 0.060 |
Why?
|
Information Dissemination | 1 | 2012 | 1106 | 0.060 |
Why?
|
Risk | 2 | 2013 | 9684 | 0.060 |
Why?
|
New England | 2 | 2023 | 1021 | 0.060 |
Why?
|
Cohort Studies | 8 | 2022 | 40389 | 0.060 |
Why?
|
Length of Stay | 1 | 2016 | 6295 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3021 | 0.050 |
Why?
|
Proteins | 1 | 1998 | 6082 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3922 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2018 | 25470 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 285 | 0.050 |
Why?
|
Risk Factors | 8 | 2022 | 71974 | 0.050 |
Why?
|
Peptides | 1 | 2014 | 4395 | 0.050 |
Why?
|
MEDLINE | 1 | 2001 | 124 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4671 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1585 | 0.050 |
Why?
|
Food, Formulated | 1 | 2001 | 109 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11347 | 0.050 |
Why?
|
Neurofibroma | 1 | 2001 | 101 | 0.050 |
Why?
|
Drug Utilization | 1 | 2007 | 1181 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2004 | 989 | 0.050 |
Why?
|
Anticoagulants | 2 | 2013 | 4582 | 0.050 |
Why?
|
Patient Selection | 2 | 2019 | 4211 | 0.050 |
Why?
|
Placebos | 1 | 2005 | 1678 | 0.050 |
Why?
|
Emotions | 1 | 2012 | 2642 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8605 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2732 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 2365 | 0.050 |
Why?
|
Algorithms | 4 | 2018 | 13872 | 0.050 |
Why?
|
Behcet Syndrome | 1 | 2001 | 86 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2005 | 14740 | 0.040 |
Why?
|
Viral Load | 1 | 2009 | 3299 | 0.040 |
Why?
|
Syndrome | 2 | 2008 | 3241 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2015 | 13002 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10142 | 0.040 |
Why?
|
Thrombosis | 1 | 2013 | 2961 | 0.040 |
Why?
|
Incidence | 4 | 2013 | 20913 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2001 | 3504 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2019 | 5058 | 0.040 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 1998 | 29 | 0.040 |
Why?
|
Integrins | 1 | 2003 | 845 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2006 | 1824 | 0.040 |
Why?
|
Smoking | 2 | 2013 | 8960 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2005 | 1516 | 0.040 |
Why?
|
Micronutrients | 1 | 2001 | 364 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2004 | 1465 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15036 | 0.040 |
Why?
|
Regression Analysis | 4 | 2013 | 6452 | 0.040 |
Why?
|
Iron | 1 | 2006 | 1776 | 0.040 |
Why?
|
Duodenal Diseases | 1 | 1998 | 102 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1643 | 0.040 |
Why?
|
Colectomy | 1 | 2023 | 681 | 0.040 |
Why?
|
Neuroblastoma | 1 | 1986 | 1214 | 0.040 |
Why?
|
Schools | 1 | 2006 | 1419 | 0.040 |
Why?
|
Administration, Oral | 2 | 2014 | 3909 | 0.040 |
Why?
|
Proctitis | 1 | 1997 | 40 | 0.040 |
Why?
|
Minocycline | 1 | 1998 | 164 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2023 | 961 | 0.040 |
Why?
|
Canada | 3 | 2007 | 2021 | 0.040 |
Why?
|
Hepatitis, Autoimmune | 1 | 1998 | 134 | 0.040 |
Why?
|
Cerebral Palsy | 1 | 2001 | 457 | 0.040 |
Why?
|
Deglutition Disorders | 1 | 2003 | 607 | 0.040 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 27 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2017 | 236 | 0.040 |
Why?
|
Students | 1 | 2006 | 1637 | 0.040 |
Why?
|
Gastroesophageal Reflux | 2 | 2000 | 782 | 0.040 |
Why?
|
Caspase 8 | 1 | 2016 | 196 | 0.030 |
Why?
|
Interleukins | 1 | 2001 | 788 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 1996 | 156 | 0.030 |
Why?
|
Ulcer | 1 | 1997 | 205 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6998 | 0.030 |
Why?
|
Body Mass Index | 2 | 2007 | 12655 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 759 | 0.030 |
Why?
|
Physician Assistants | 1 | 2018 | 194 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 879 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1238 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 35326 | 0.030 |
Why?
|
Body Height | 2 | 2014 | 1577 | 0.030 |
Why?
|
Sucrase | 1 | 2015 | 54 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 6686 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 296 | 0.030 |
Why?
|
Endoscopy, Digestive System | 2 | 2011 | 345 | 0.030 |
Why?
|
Neural Conduction | 1 | 2016 | 469 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2023 | 1445 | 0.030 |
Why?
|
Nurse Practitioners | 1 | 2018 | 270 | 0.030 |
Why?
|
Demography | 2 | 2012 | 1650 | 0.030 |
Why?
|
Hospitalization | 4 | 2018 | 10208 | 0.030 |
Why?
|
Comorbidity | 3 | 2015 | 10362 | 0.030 |
Why?
|
Solubility | 1 | 1996 | 1083 | 0.030 |
Why?
|
Vitamin A | 1 | 1998 | 613 | 0.030 |
Why?
|
Genotype | 2 | 2015 | 12951 | 0.030 |
Why?
|
Databases, Factual | 3 | 2018 | 7690 | 0.030 |
Why?
|
Depressive Disorder, Major | 2 | 2012 | 4606 | 0.030 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2013 | 62 | 0.030 |
Why?
|
Hematoma | 1 | 1998 | 754 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2748 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7275 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4791 | 0.030 |
Why?
|
Vitamin E | 1 | 1998 | 870 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1352 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 664 | 0.030 |
Why?
|
Neodymium | 1 | 2012 | 21 | 0.030 |
Why?
|
Adaptation, Psychological | 2 | 2015 | 2564 | 0.030 |
Why?
|
Middle Aged | 10 | 2022 | 212863 | 0.030 |
Why?
|
Quality Improvement | 2 | 2018 | 3730 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1998 | 2238 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4522 | 0.030 |
Why?
|
Drug Approval | 1 | 2019 | 742 | 0.030 |
Why?
|
Genes, rRNA | 1 | 2012 | 70 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2012 | 12948 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2009 | 2974 | 0.030 |
Why?
|
Escherichia coli | 1 | 2004 | 4220 | 0.030 |
Why?
|
Ileal Diseases | 1 | 2012 | 74 | 0.030 |
Why?
|
Animals | 4 | 2017 | 168368 | 0.030 |
Why?
|
Software Design | 1 | 2012 | 175 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1145 | 0.030 |
Why?
|
Inflammasomes | 1 | 2016 | 486 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2017 | 14558 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 577 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1778 | 0.030 |
Why?
|
Atrophy | 1 | 1996 | 1571 | 0.030 |
Why?
|
Psychometrics | 2 | 2012 | 2995 | 0.020 |
Why?
|
Software | 2 | 2018 | 4423 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2005 | 11985 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1998 | 1127 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3151 | 0.020 |
Why?
|
Factor VIII | 1 | 2013 | 348 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2012 | 265 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2016 | 13880 | 0.020 |
Why?
|
Sex Factors | 2 | 2022 | 10398 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19220 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 422 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 563 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2013 | 888 | 0.020 |
Why?
|
Internal-External Control | 1 | 2012 | 362 | 0.020 |
Why?
|
Risk Assessment | 2 | 2010 | 23294 | 0.020 |
Why?
|
Thrombophilia | 1 | 2013 | 305 | 0.020 |
Why?
|
Colonic Diseases | 1 | 2012 | 202 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1820 | 0.020 |
Why?
|
Esophagoscopy | 1 | 1992 | 390 | 0.020 |
Why?
|
Diffusion | 1 | 2012 | 832 | 0.020 |
Why?
|
Women | 1 | 2012 | 230 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 894 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 665 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1999 | 1086 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 2022 | 0.020 |
Why?
|
Leptin | 1 | 1998 | 1589 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2141 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2067 | 0.020 |
Why?
|
Biodiversity | 1 | 2012 | 337 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5959 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3382 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4640 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 760 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2131 | 0.020 |
Why?
|
Child Development | 2 | 2014 | 2213 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2208 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1992 | 1096 | 0.020 |
Why?
|
Pilot Projects | 1 | 2002 | 8275 | 0.020 |
Why?
|
Metagenomics | 1 | 2012 | 428 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8977 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2723 | 0.020 |
Why?
|
Mutation | 2 | 2016 | 29658 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1997 | 3770 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2502 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2001 | 2945 | 0.020 |
Why?
|
Defecation | 1 | 2009 | 187 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4935 | 0.020 |
Why?
|
Catheterization | 1 | 2013 | 1466 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2016 | 3193 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2448 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1749 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 5959 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2118 | 0.020 |
Why?
|
Sexual Maturation | 1 | 2009 | 265 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2409 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1329 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7128 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4137 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10945 | 0.020 |
Why?
|
Prednisolone | 1 | 2007 | 332 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5522 | 0.020 |
Why?
|
Amino Acids | 1 | 2012 | 1727 | 0.020 |
Why?
|
Thinness | 1 | 2009 | 475 | 0.020 |
Why?
|
Ganglioneuroma | 1 | 1986 | 58 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12804 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2373 | 0.020 |
Why?
|
Eosinophilia | 2 | 2000 | 531 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7788 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3344 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17384 | 0.020 |
Why?
|
Myoclonus | 1 | 1986 | 104 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2012 | 1423 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4419 | 0.020 |
Why?
|
Social Support | 1 | 2015 | 2112 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4035 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6028 | 0.020 |
Why?
|
Urography | 1 | 1986 | 308 | 0.020 |
Why?
|
Phylogeny | 1 | 2012 | 2789 | 0.020 |
Why?
|
Radiology | 1 | 2018 | 2080 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1890 | 0.020 |
Why?
|
Affect | 1 | 2012 | 1475 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 1986 | 289 | 0.020 |
Why?
|
Cyclosporine | 1 | 2007 | 781 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23355 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 254 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4374 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6942 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1986 | 267 | 0.010 |
Why?
|
Heparin | 1 | 2011 | 1637 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2410 | 0.010 |
Why?
|
Insurance, Health | 1 | 2015 | 2491 | 0.010 |
Why?
|
Chemoprevention | 1 | 2005 | 323 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2589 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3419 | 0.010 |
Why?
|
Immune System Diseases | 1 | 2005 | 262 | 0.010 |
Why?
|
Diarrhea, Infantile | 1 | 2002 | 109 | 0.010 |
Why?
|
Eye Movements | 1 | 1986 | 505 | 0.010 |
Why?
|
Motivation | 1 | 2012 | 1965 | 0.010 |
Why?
|
Health Surveys | 1 | 2012 | 4022 | 0.010 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2001 | 24 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2002 | 183 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5631 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10455 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5948 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1986 | 2028 | 0.010 |
Why?
|
Hemorrhage | 1 | 2013 | 3441 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3087 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 1951 | 0.010 |
Why?
|
Gastrostomy | 1 | 2003 | 307 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2012 | 2067 | 0.010 |
Why?
|
Postoperative Period | 1 | 2005 | 1835 | 0.010 |
Why?
|
Interleukin-15 | 1 | 2001 | 182 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3609 | 0.010 |
Why?
|
Nutritional Requirements | 1 | 2001 | 283 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 303 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2012 | 6963 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2003 | 932 | 0.010 |
Why?
|
Steroids | 1 | 2004 | 925 | 0.010 |
Why?
|
Recovery of Function | 1 | 2009 | 2924 | 0.010 |
Why?
|
Rectum | 1 | 2004 | 900 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6516 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12049 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3497 | 0.010 |
Why?
|
Aged | 4 | 2014 | 162698 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5113 | 0.010 |
Why?
|
Zinc | 1 | 2001 | 683 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7626 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2001 | 1262 | 0.010 |
Why?
|
Tuberculosis | 1 | 2009 | 1892 | 0.010 |
Why?
|
Brain Diseases | 1 | 1986 | 1551 | 0.010 |
Why?
|
Overweight | 1 | 2007 | 2355 | 0.010 |
Why?
|
Palliative Care | 1 | 2011 | 3461 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15500 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2005 | 6871 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 16764 | 0.010 |
Why?
|
Acne Vulgaris | 1 | 1998 | 299 | 0.010 |
Why?
|
Eosinophils | 1 | 1999 | 954 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1999 | 2558 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2004 | 2583 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2009 | 4365 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1986 | 2521 | 0.010 |
Why?
|
Esophagus | 1 | 1999 | 1017 | 0.010 |
Why?
|
Ultrasonography | 1 | 1986 | 5941 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1986 | 2706 | 0.010 |
Why?
|
Cytokines | 1 | 2006 | 7298 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1735 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1986 | 10961 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1986 | 4216 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 1998 | 20055 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81002 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2001 | 3752 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10247 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1986 | 9122 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 9812 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1986 | 8791 | 0.000 |
Why?
|
Neprilysin | 1 | 1985 | 439 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1986 | 12985 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2003 | 57650 | 0.000 |
Why?
|
Antigens, Neoplasm | 1 | 1985 | 1977 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1985 | 4663 | 0.000 |
Why?
|